AMD Strategically Invests $20 Million in Absci, a Pioneering AI-Driven Drug Discovery Firm - AI

7 x 24 Track global technological trends

Hot Topic

Day

News Topic

AMD Strategically Invests $20 Million in Absci, a Pioneering AI-Driven Drug Discovery Firm

2025-01-08

Absci has forged a strategic partnership with AMD, whereby AMD will allocate $20 million in funding to collaboratively deploy Instinct accelerators and ROCm software. The objective of this initiative is to enhance AI-powered drug discovery processes, fostering biotherapeutic innovation, cost reduction, and expedited R&D timelines. On January 15, both entities aim to demonstrate the exceptional performance of Instinct accelerators in intricate biological applications.

Previous page：JD.com's Government and Enterprise Business Recogn...

Next page：Microsoft Pulls Bing Image Creator Model Amid User...

Return to List

Hot Reading

22 hour ago

Perplexity offers more than twice its total valuation to buy Chrome from Google

21 hour ago

Why it’s a mistake to ask chatbots about their mistakes

20 hour ago

ChatGPT’s model picker is back, and it’s complicated

2 day ago

Grok Is So Deeply Antisemitic That Showing It a Picture of Some Random Clouds in the Sky Prompts an Outrageously Offensive Answer